SMART-CHOICE 3: Clopidogrel Shows Benefit Over Aspirin Monotherapy Following PCI – American College of Cardiology
Clopidogrel monotherapy was found to be more effective than aspirin monotherapy in lowering risk of major adverse cardiac and cerebrovascular events among patients at high risk of recurrent ischemic events who completed a standard duration of dual antiplatelet therapy (DAPT) following PCI, according to new research presented during a Late-Breaking Clinical Trial session at ACC.25 in Chicago and simultaneously published in The Lancet. Between August 2020 and July 2023, in an open-label trial, 5,506
